⌘K
Loading ticker…
As of 2026-09-10, Starling Oncology, Inc. Common Stock (STLN) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 6.0%, relative volume 0.60×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Not enough history to compute monthly seasonality for STLN.